companies / terraytx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 120,000,000120.0M | ○ |
|---|---|---|
| founded | null | |
| hq | Los Angeles CA | |
| industry | unknown | |
| stage | series-b+ |
Terray Therapeutics is a drug discovery company that combines AI with high-throughput experimentation to design small-molecule medicines. It develops therapeutics across multiple disease areas through its EMMI platform. Terray is vertically integrated, inventing its own hardware and chemical datasets rather than buying third-party tools.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-10-01 | series-b | 120,000,000120.0M | null | ○ |
Vercel, Next.js, Sanity, Sanity.io, web-vitals, React, Webpack
| fact | status | src |
|---|---|---|
| Series B, $120.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |